The induction of specific antitumor immunity by in vivo treatment with interleukin-1 and sonicated tumor extract in a murine model
- 1 June 1994
- journal article
- Published by Springer Nature in Surgery Today
- Vol. 24 (6) , 561-563
- https://doi.org/10.1007/bf01884580
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Active specific immunotherapy with Newcastle-diseasevirus-modified autologous tumor cells following resection of liver metastases in colorectal cancerCancer Immunology, Immunotherapy, 1992
- INTERLEUKIN-1 AS AN ADJUVANT FOR ACTIVE SPECIFIC IMMUNOTHERAPY IN A MURINE TUMOR-MODEL1990
- Renal cell carcinoma treated by vaccines for active specific immunotherapy: Correlation of survival with skin testing by autologous tumor cellsCancer Immunology, Immunotherapy, 1990
- Interleukin-1 and Its Biologically Related CytokinesPublished by Elsevier ,1989
- Site-specific mutagenesis of the human interleukin-1β gene: Structure-function analysis of the cysteine residuesBiochemical and Biophysical Research Communications, 1988
- [Breast cancer-specific immunity evaluated by a new in vitro method--IL-2 enhanced MLTR].1987
- There is more than one interleukin 1Immunology Today, 1986
- Prospectively randomized trial of adjuvant active‐specific immunotherapy for human colorectal cancerCancer, 1985
- Antitumor and therapeutic effects of spleen cells from tumor-bearing mice cultured with T cell growth factor and soluble tumor extractCancer Immunology, Immunotherapy, 1984
- A phase II study on the postsurgical management of stage II malignant melanoma with a Newcastle disease virus oncolysateCancer, 1983